Aesculus hippocastanum (Horse chestnut)

Alternative Medicine Review

Volumn 14, Issue 3, 2009, Pages 278-283

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

AESCULUS HIPPOCASTANUM EXTRACT; ANTICOAGULANT AGENT; DIOSMIN; ESCIN; ESCULIN; PENTOXIFYLLINE; PLACEBO; RUTOSIDE DERIVATIVE; TROXERUTIN;

AESCULUS HIPPOCASTANUM; ANAPHYLAXIS; ANTIINFLAMMATORY ACTIVITY; APPLICATION SITE PRURITUS; APPLICATION SITE REACTION; BLOOD VESSEL PERMEABILITY; CHRONIC VEIN INSUFFICIENCY; CLINICAL TRIAL; COMPRESSION GARMENT; DIZZINESS; DOSE RESPONSE; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG MEGADOSE; DRUG POTENTIATION; DRUG SAFETY; EDEMA; GASTROINTESTINAL SYMPTOM; HEARING LOSS; HEMORRHOID; HERB DRUG INTERACTION; HUMAN; INNER EAR DISEASE; LEUKOCYTE ACTIVATION; LEUKOCYTE ADHERENCE INHIBITION; NONHUMAN; PLEURISY; POSTOPERATIVE EDEMA; PRURITUS; RECOMMENDED DRUG DOSE; REVIEW; ULCER; UNSPECIFIED SIDE EFFECT; VARICOSIS; VENOUS STASIS;

AESCULUS; ANIMALS; EDEMA; EVIDENCE-BASED MEDICINE; HEMORRHOIDS; HUMANS; PHYTOTHERAPY; PLANT EXTRACTS; VARICOSE VEINS; VENOUS INSUFFICIENCY;

EID: 70350050891     PISSN: 10895159     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (39)

1. Aesculus hippocastanum L. (horse chestnut). http://plants.usda.gov/java/ profile?symbol=AEHI [Accessed June 16, 2009]
2. Aesculus hippocastanum. http://en.wikipedia.org/wiki/Aesculus- hippocastanum [Accessed June 27, 2009]
3. Chestnut, Horse. http://www.botanical.com/botanical/mgmh/c/chehor58.html [Accessed June 16, 2009]
4. Sirtori CR. Aescin: pharmacology, pharmacokinetics and therapeutic profile. Pharmacol Res 2001;44:183-193. (Pubitemid 32889461)
5. Horse chestnut (Aesculus hippocastanum L.). http://www.mayoclinic.com/ health/horse-chestnut/NS-patient-horsechestnut [Accessed June 16, 2009]
6. Bombardelli E, Morazzoni P. Aesculus hippocastanum L. Fitoterapia 1996;67:483-511. (Pubitemid 27062249)
7. Lorenz D, Marek ML. The active therapeutic principle of horse chestnut (Aesculus hippocastanum). Part 1. Classification of the active substance. Arzneimittelforschung 1960;10:263-272. [Article in German]
8. Mrwa U, Guth K, Haist C, et al. Calcium-requirement for activation of skinned vascular smooth muscle from spontaneously hypertensive (SHRSP) and normotensive control rats. Life Sci 1986:38:191-196. (Pubitemid 16161882)
9. Pearson PJ, Vanhoutte PM. Vasodilator and vasoconstrictor substances produced by the endothelium. Rev Physiol Biochem Pharmacol 1993;122:1-67.
10. Satoh S, Kreutz R, Wilm C, et al. Augmented agonist-induced Ca(2+)-sensitization of coronary artery contraction in genetically hypertensive rats. Evidence for altered signal transduction in the coronary smooth muscle cells. J Clin Invest 1994;94:1397-1403. (Pubitemid 24309856)
11. Arnould T, Janssens D, Michiels C, Remacle J. Effect of aescine on hypoxia-induced activation of human endothelia cells. Eur J Pharmacol 1996;315:227-233. (Pubitemid 26390942)
12. Bazzoni G, Dejana E, Del Maschio A. Platelet-neutrophil interactions. Possible relevance in the pathogenesis of thrombosis and inflammation. Haematologica 1991;76:491-499.
13. Guillaume M, Padioleau V. Veinotonic effect, vascular protection, antiinflammatory and free radical scavenging properties of horse chestnut extract. Arzneimittelforschung 1994;44:25-35. (Pubitemid 24036875)
14. Panigati D. The pharmacology of escin, a saponin from Aesculus hippocastanum L. II. Pharmacodynamics of escin. Chapter I. Boll Chim Farm 1992;131:242-246. [Article in Italian]
15. Annoni F, Mauri A, Marincola F, Resele LF. Venotonic activity of escin on the human saphenous vein. Arzneimittelforschung 1979;29:672-675. (Pubitemid 9154686)
16. Venous insufficiency. http://www.nlm.nih.gov/medlineplus/ency/article/ 000203.htm [Accessed July 7, 2009]
17. Vein Clinics of America. Chronic venous insufficiency. http://www.veinclinics.com/cme/skin-findings.html#ulcer. [Accessed July 14, 2009]
18. Siebert U, Brach M, Sroczynski G, Berla K. Efficacy, routine effectiveness, and safety of horsechestnut seed extract in the treatment of chronic venous insufficiency. A meta-analysis of randomized controlled trials and large observational studies. Int Angiol 2002;21:305-315. (Pubitemid 36322366)
19. Diehm C, Trampisch HJ, Lange S, Schmidt C. Comparison of leg compression stocking and oral horse-chestnut seed extract therapy in patients with chronic venous insufficiency. Lancet 1996;347:292-294. (Pubitemid 26041041)
20. Pittler MH, Ernst E. Horse-chestnut seed extract for chronic venous insufficiency. A criteria-based systematic review. Arch Dermatol 1998;134:1356-1360. (Pubitemid 28543649)
21. Horse chestnut seed extract for the treatment of chronic venous insufficiency. http://www.moh.govt.nz/moh.nsf/pagesmh/8370/$File/HM1- Horse+chestnut+and+chronic+venous+insufficiency-2004.pdf [Accessed July 28, 2009]
22. Masuhr T, Holscher U, Honold E. Benefit-risk evaluation of Venoplant retard, a product standardized on aescin and based on the extract of horse chestnut seed, in patients suffering from chronic venous insufficiency. Top Med 1994;8:21-24. [Article in German]
23. Greeske K, Pohlmann BK. Horse chestnut seed extract - an effective therapy principle in general practice. Drug therapy of chronic venous insufficiency. Fortschr Med 1996;114:196-200. [Article in German]
24. Leskow P. Effective treatment with horse chestnut extract in chronic venous insufficiency. Therapiewoche 1996;46:874-877. [Article in German]
25. Marzin L, Parpex P, Schadeck M, Vin F. Study of the effect of a new vascular protectant Venostasin, administered for 2 months in chronic venous insufficiency of the lower extremities. [Unpublished data-1991]
26. Erdlen F. Clinical efficacy of Venostasin. A double blind trial. Med Welt 1989;40:994-996. (Pubitemid 19221847)
27. Erler M. Horse chestnut seed extract in the therapy of peripheral venous edema: clinical therapies in comparison. Med Welt 1991;42:593-596. [Article in German]
28. Kalbfleisch W, Pfalzgraf H. Odemprotektiva: aquipotente dosierung: roßkastaniensamenextraktund O-b-hydroxyethylrutoside im vergleich. Therapiewoche 1989;39:3703-3707. [Article in German]
29. Rehn D, Unkauf M, Klein P, et al. Comparative clinical efficacy and tolerability of oxerutins and horse chestnut extract in patients with chronic venous insufficiency. Arzneimittelforschung 1996;46:483-487.
30. Suter A, Bommer S, Rechner J. Treatment of patients with venous insufficiency with fresh plant horse chestnut seed extract: a review of 5 clinical studies. Adv Ther 2006;23:179-190.
31. Leach MJ, Pincombe J, Foster G. Clinical efficacy of horsechestnut seed extract in the treatment of venous ulceration. J Wound Care 2006;15:159-167.
32. Hefti F, Kappeler U. Clinical investigation of aescin ampoules in case of post-operative and post-traumatic edema (author's transl). Schweiz Rundsch Med Prax 1975;64:73-77. [Article in German]
33. Wilhelm K, Feldmeier C. Thermometric investigations about the efficacy of beta-escin to reduce postoperative edema (author's transl). Med Klin 1977;72:128-134. [Article in German] (Pubitemid 8017087)
34. Otto H, Arfeen N. Treatment of postoperative edema with Reparil. Report of experiences (author's transl). MMW Munch Med Wochenschr 1974;116:1085-1088. [Article in German]
35. Pirard J, Gillet P, Guffens JM, Defrance P. Double blind study of Reparil in proctology. Rev Med Liege 1976;31:343-345. [Article in French]
36. Siegers CP, Syed Ali S, Tegtmeier M. Aescin and troxerutin as a successful combination for the treatment of inner ear disturbances. Phytomedicine 2008;15:160-163.
37. Brinker F. Herb Contraindications and Drug Interactions, 3rd ed. Sandy, OR: Eclectic Medical Publications; 2001:120.
38. European Scientific Cooperative of Phytotherapy. Medicinal Uses of Plant Drugs. Exeter, Devon, UK: ESCOP; 1999.
39. Escribano MM, Munoz-Bellido FJ, Velazquez E, et al. Contact urticaria due to aescin. Contact Dermatitis 1997:37:233.